The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...

Johnson & Johnson has wasted no time expanding its portfolio. In the past two years it has invested more than $60 billion into research and development (R&D), as well as mergers and acquisitions, ...

Among its various international efforts, USAID works to strengthen global supply chains and promote access to essential ...

Pharma industry groups are sounding the alarm, warning that President Donald Trump’s tariffs could worsen drug shortages, ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

Q Earnings: $3.4 billion (-17%) FY Revenues: $88.8 billion (+4%) FY Earnings: $14.1 billion (+6%) Comments: Innovative Medicin ...

President Donald Trump’s plan to impose tariffs on goods from Mexico, Canada and China is partly aimed at combating the ...

Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $166 from $162 and keeps a Neutral rating on the ...

The association representing thousands of FBI agents is urging congressional leaders to protect the jobs of employees at risk ...

The game's on-air broadcast showed a referee speaking with San Antonio acting head coach Mitch Johnson and Memphis head coach ...

This affiliate content is not influenced by our advertising relationships, but AP and Data Skrive might earn commissions from ...